NEW YORK (GenomeWeb News) – Shares of Sequenom rose 17.6 percent to close at $5.95 in Thursday trade on the Nasdaq after Cantor Fitzgerald initiated coverage of the firm with a “buy” rating.
 
Cantor Fitzgerald also placed a $12 price target on Sequenom’s shares and expects the firm to become profitable in 2010. The Cantor Fitzgerald analyst cited the revenue growth potential of Sequenom’s MassArray system.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.